Doxy-Post-exposure Prophylaxis
Condition(s):Sexually Transmitted DiseasesLast Updated:June 9, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Sexually Transmitted DiseasesLast Updated:June 9, 2023Recruiting
Condition(s):TuberculosisLast Updated:January 25, 2024Recruiting
Condition(s):Resectable Pancreatic CancerLast Updated:July 3, 2023Completed
Condition(s):Parkinson DiseaseLast Updated:August 8, 2022Recruiting
Condition(s):Post-exposure Prophylaxis; Sexually Transmitted Diseases; DoxycyclineLast Updated:August 23, 2023Not yet recruiting
Condition(s):Cystic FibrosisLast Updated:March 30, 2017Completed
Condition(s):Type 2 Diabetes; ObesityLast Updated:January 13, 2020Completed
Condition(s):SyphilisLast Updated:October 31, 2022Recruiting
Condition(s):Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary SyndromeLast Updated:April 27, 2021Terminated
Condition(s):Adhesive Capsulitis; Adhesive Capsulitis of Unspecified Shoulder; Frozen ShoulderLast Updated:January 18, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.